1-7 of 7
Aaron Seth Rosenberg, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Blinatumomab/Lenalidomide in Relapsed/Refractory Non-Hodgkin's Lymphoma: A Phase I California Cancer Consortium Study of Safety, Efficacy and Immune Correlative Analysis

Christina Poh, MD, Paul Frankel, PhD, Christopher Ruel, Mehrdad Abedi, MD, Emily Schwab, BS, Caitlin L. Costello, MD, Jasmine Zain, MD, Lihua E Budde, MD PhD, Basem M. William, MRCP,MD, Francine M. Foss, MD, Brian A Jonas, MD PhD, Aaron Seth Rosenberg, MD, Edward Newman, PhD, Joseph Tuscano, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 760.
https://doi.org/10.1182/blood-2019-124254
Published: 2019
Journal Articles

Phase I Study of Escalating Doses of Carfilzomib with Hyper-CVAD in Patients with Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Samantha C Fisch, BS, Brian A Jonas, MD PhD, Joseph Tuscano, MD, Aaron Seth Rosenberg, MD, Rasmus T Hoeg, MD, Mehrdad Abedi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3884.
https://doi.org/10.1182/blood-2019-121991
Published: 2019
Journal Articles

Changing Incidence of Major Cardiovascular Events in Multiple Myeloma Patients over Time

Aaron Seth Rosenberg, MD, Qian Li, MS, Ann M Brunson, MS, Joseph Tuscano, MD, Ted Wun, MD, Theresa H.M. Keegan, PhD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 3598.
https://doi.org/10.1182/blood-2018-99-117959
Published: 2018
Journal Articles

Effect of Autologous Hematopoietic Stem Cell Transplant (aHSCT) on the Development of Second Primary Malignancies (SPM) in Multiple Myeloma Patients

Aaron Seth Rosenberg, MD, Ann M Brunson, MS, Joseph M Tuscano, MD, Brian A Jonas, MD PhD, Mehrdad Abedi, MD, Ted Wun, MD FACP, FRCPA, Theresa H.M. Keegan, PhD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 332.
https://doi.org/10.1182/blood.V130.Suppl_1.332.332
Published: 2017
Journal Articles

Retrospective Analysis of Adult Relapsed and Refractory Acute Leukemia Patients Treated with FLAG at a Comprehensive Cancer Center

Matthew Tenold, MD, Benjamin Moskoff, PharmD, Rajeev Krishnan, MD, Aaron Seth Rosenberg, MD, Brian A Jonas, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3872.
https://doi.org/10.1182/blood.V130.Suppl_1.3872.3872
Published: 2017
Journal Articles

A Phase 1 Study of Everolimus and Bendamustine in Patients with Relapsed or Refractory Lymphoid Malignancies and Myeloma

Julian R Davis, MD MA, Brian A Jonas, MD PhD, Joseph M Tuscano, MD, Aaron Seth Rosenberg, MD, Mehrdad Abedi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4038.
https://doi.org/10.1182/blood.V130.Suppl_1.4038.4038
Published: 2017
Journal Articles

Morbid Progression Is Common Among Patients with Multiple Myeloma and Is Associated with Shortened Overall Survival: Validation of the Progression-Free Survival Endpoint

Aaron Seth Rosenberg, MD, Thierry Facon, MD, Safiya Abouzaid, MPH, PharmD, Shankar Srinivasan, PhD, Weiyuan Chung, Kejal Parikh, BSPharm, MS, Joseph Tuscano, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3113.
https://doi.org/10.1182/blood.V130.Suppl_1.3113.3113
Published: 2017